Today: 12 April 2026

Why Wells Fargo stock (WFC) is up today as the yield curve steepens — the next catalyst to watch

Why Wells Fargo stock (WFC) is up today as the yield curve steepens — the next catalyst to watch

Wells Fargo shares rose 1.2% to $93.44 by midafternoon Wednesday as U.S. bank stocks gained alongside a steeper Treasury yield curve. The KBW Nasdaq Bank Index advanced 1.23%. Wells Fargo priced 5.50% fixed-rate callable notes due 2046, per an SEC filing. The bank projects $50 billion in net interest income for 2026 and reported $612 million in severance costs tied to layoffs.
4 February 2026
Analog Devices stock jumps again — CEO sale filing, chip M&A and Feb. 18 earnings in focus

Analog Devices stock jumps again — CEO sale filing, chip M&A and Feb. 18 earnings in focus

Analog Devices shares rose 3.3% to $321.46 Wednesday afternoon, rebounding after Tuesday’s drop. The move followed Texas Instruments’ $7.5 billion deal to acquire Silicon Labs, which reignited M&A speculation in analog chips. CEO Vincent Roche sold 10,000 shares last week under a preset plan. Investors await Analog Devices’ earnings on Feb. 18.
Chipotle stock rebounds from early drop as CMG traders rethink 2026 outlook

Chipotle stock rebounds from early drop as CMG traders rethink 2026 outlook

Chipotle shares rebounded to $40.00, up 2.1%, after dropping to $36.50 earlier Wednesday. The company reported Q4 revenue of $3.0 billion, but comparable sales fell 2.5% and transactions dropped 3.2%. Chipotle projects flat comparable sales for 2026 and plans 1–2% menu price hikes to offset rising costs, especially for beef. Investors await further details in the upcoming SEC filing.
Eli Lilly stock jumps as 2026 forecast beats estimates on Zepbound, Mounjaro demand

Eli Lilly stock jumps as 2026 forecast beats estimates on Zepbound, Mounjaro demand

Eli Lilly shares surged about 9% Wednesday after reporting a 43% jump in quarterly revenue to $19.3 billion and issuing a bullish 2026 outlook. Mounjaro and Zepbound drove results, but executives warned pricing will weigh on future growth. Investors await the FDA’s April decision on Lilly’s oral obesity drug. The stock’s rally contrasted with declines in major indexes.
Marvell Technology stock slips as Celestial AI deal dilution meets a wider chip selloff

Marvell Technology stock slips as Celestial AI deal dilution meets a wider chip selloff

Marvell Technology shares fell about 2% to $74.06 Wednesday after the company closed its $1 billion acquisition of Celestial AI and warned of higher short-term costs and share dilution. Marvell issued over 24 million unregistered shares for the deal and may issue more if revenue targets are met. Investors are watching for signs of demand and integration ahead of the company’s earnings report.
Qualcomm stock price rises ahead of earnings — what QCOM investors watch after the bell

Qualcomm stock price rises ahead of earnings — what QCOM investors watch after the bell

Qualcomm shares rose 2.8% to $151.33 Wednesday afternoon ahead of its fiscal first-quarter earnings report, bucking a 3.6% drop in the iShares Semiconductor ETF. Wall Street expects $12.13 billion in revenue and $3.39 adjusted EPS for the December quarter. Trading volume in Qualcomm surpassed its 50-day average. Investors are watching for guidance on handset demand and profit margins.
AT&T stock rises on Amazon cloud-satellite tie-up as traders eye fiber rollout

AT&T stock rises on Amazon cloud-satellite tie-up as traders eye fiber rollout

AT&T shares rose 1.5% to $27.22 after announcing a deeper partnership with Amazon Web Services to move network workloads to the cloud and expand broadband via Amazon’s satellites. The move follows AT&T’s $5.75 billion acquisition of Lumen’s fiber business, adding over 1 million subscribers. Wall Street awaits cost details, with more information expected at Mobile World Congress in March.
AbbVie stock drops after Rinvoq sales miss, even as 2026 profit forecast tops estimates

AbbVie stock drops after Rinvoq sales miss, even as 2026 profit forecast tops estimates

AbbVie shares fell 2.5% to $219.98 Wednesday after Rinvoq sales missed forecasts, despite the company raising its 2026 profit outlook. Q4 adjusted earnings reached $2.71 per share on $16.618 billion revenue; Skyrizi sales rose 32.5%, while Humira dropped 25.9%. AbbVie announced a three-year Medicaid pact with the Trump administration and pledged $100 billion in U.S. investments.
Lear stock jumps 11% as Q4 results, 2026 cash-flow guide put buybacks back in focus

Lear stock jumps 11% as Q4 results, 2026 cash-flow guide put buybacks back in focus

Lear Corp shares surged 11% to $132.94 after posting a 5% rise in Q4 revenue to $6.0 billion and raising its 2026 outlook. Adjusted EPS climbed to $3.41, but free cash flow fell to $281 million. The company projects 2026 sales of up to $24.01 billion and free cash flow up to $650 million. Other auto-parts stocks also rallied, with Adient up nearly 12%.
AST SpaceMobile (ASTS) stock slides as AT&T taps Amazon Leo for satellite broadband

AST SpaceMobile (ASTS) stock slides as AT&T taps Amazon Leo for satellite broadband

AST SpaceMobile shares fell 10% to $103.73 after AT&T announced a new satellite broadband partnership with AWS and Amazon Leo, focused on business customers. Trading volume topped 15.9 million shares. The drop followed investor concerns over AT&T’s commitment to AST’s direct-to-phone satellite plans. AST’s next satellite launch is scheduled for late February.
4 February 2026
Pizza Hut to Close 250 U.S. Stores as Yum’s ‘Hut Forward’ Reset Kicks In

Pizza Hut to Close 250 U.S. Stores as Yum’s ‘Hut Forward’ Reset Kicks In

Yum Brands will close about 250 underperforming Pizza Hut locations in the U.S. by mid-2026 as part of its “Hut Forward” turnaround plan. Pizza Hut’s U.S. same-store sales dropped 3% in the fourth quarter and 5% for 2025. Executives said the strategic review could lead to a sale of the chain. Pizza Hut ended 2025 with 19,974 global locations, down from 20,225 a year earlier.
4 February 2026
Carlisle stock jumps 11% after earnings beat and $1 billion buyback plan

Carlisle stock jumps 11% after earnings beat and $1 billion buyback plan

Carlisle Companies’ shares rose 10.7% to $394 after beating Q4 profit estimates and forecasting low single-digit revenue growth with a 0.50-point margin boost for 2026. Management expects a weak first quarter and flat second quarter, but stronger results in the second half. Q4 revenue was $1.13 billion; adjusted EPS fell to $3.90 from $4.47. The company announced up to $1 billion in buybacks for 2026.
Fortive stock jumps on upbeat 2026 profit view after Q4 beat, buybacks

Fortive stock jumps on upbeat 2026 profit view after Q4 beat, buybacks

Fortive shares jumped 12.4% to $61.07 after the company forecast 2026 adjusted earnings of $2.90 to $3.00 per share, topping analyst estimates. Fourth-quarter adjusted EPS reached $0.90 on $1.12 billion in revenue, with automation segment sales up 5.3%. About 8.5 million shares traded by midafternoon. Management will present at Citi and Barclays industrial conferences later this month.
4 February 2026

Stock Market Today

  • UnitedHealth Group Stock Drops Amid Challenges but Gains on Medicare Advantage Boost
    April 12, 2026, 8:04 AM EDT. UnitedHealth Group (UNH) stock fell 41% over the past year after missing earnings estimates and cutting full-year guidance, pressured by higher costs and a Justice Department probe into Medicare billing. The company plans to scale back Medicare Advantage offerings in 16 states. However, the Trump administration's approval of a 2.48% payment rate increase for Medicare Advantage in 2027 provides a positive catalyst, improving profitability and encouraging program expansion. Despite the recent stock decline, UnitedHealth remains an attractive dividend stock with a 2.9% yield. Management projects 2026 revenue of $439 billion, up from $337.6 billion in 2025, and earnings rising to $24 billion from $19 billion last year.

Latest article

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

12 April 2026
Bitcoin fell 1.4% to $71,707 on Sunday after U.S.-Iran talks in Islamabad ended without a deal. Spot bitcoin ETFs logged net inflows last week, with BlackRock and Fidelity leading Friday’s buying. Morgan Stanley launched its MSBT fund on April 8, the first Wall Street bank to debut a bitcoin ETF. U.S. inflation data showed headline CPI up 3.3% in March, while core CPI rose 2.6%.
XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

12 April 2026
XRP slipped about 1% to $1.33 on Sunday after U.S.-Iran peace talks in Islamabad ended without a deal, pressuring crypto markets. The token traded in a narrow range, with bitcoin and ether also weaker. XRP’s market cap stands at $81.7 billion, with $1.96 billion in daily volume. The token remains 63.5% below its all-time high.
Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

12 April 2026
Spot gold steadied at $4,761.79 an ounce Friday after a third weekly gain, with U.S. futures at $4,787.40. The dollar posted its biggest weekly drop since January, making gold cheaper for non-U.S. buyers. U.S.-Iran talks ended without a deal, keeping geopolitical risks high. China’s central bank increased gold reserves for a 17th month, reaching 74.38 million ounces.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Go toTop